2001
DOI: 10.1212/wnl.56.4.507
|View full text |Cite
|
Sign up to set email alerts
|

MS and neuromyelitis optica in Martinique (French West Indies)

Abstract: The island of Martinique appears to have a low to medium prevalence of MS. MS was almost unknown in FAC in Martinique until the late 1970s. The apparent recent increase may be explained by improved recognition of patients, increased availability of MRI for diagnosis, increased disease awareness among physicians, increased survival of MS patients, or an actual increase in disease frequency.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
103
2
1

Year Published

2004
2004
2016
2016

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 147 publications
(111 citation statements)
references
References 39 publications
4
103
2
1
Order By: Relevance
“…In that report, more African Americans had early pyramidal system involvement than Caucasians, leading to greater EDSS scores, while the rates of disease progression at later stages were nearly identical. Since Africans and their descendants are known to preferentially show opticospinal involvement (14,15), it is possible that early deterioration is universally characteristic of OS-MS, regardless of race.…”
Section: Discussionmentioning
confidence: 99%
“…In that report, more African Americans had early pyramidal system involvement than Caucasians, leading to greater EDSS scores, while the rates of disease progression at later stages were nearly identical. Since Africans and their descendants are known to preferentially show opticospinal involvement (14,15), it is possible that early deterioration is universally characteristic of OS-MS, regardless of race.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] NMO is a B-cell-mediated inflammatory and demyelinating disorder of the central nervous system, often presenting with severe and bilateral recurrent optic neuritis and transverse myelitis that are radiological distinguished from multiple sclerosis (MS). 5,6 Early detection of NMO is facilitated by the testing for the neuromyelitis optica immunoglobulin G (NMO-IgG) antibody.…”
Section: Case Reportmentioning
confidence: 99%
“…NMO is rare and accounts for only 1% of all demyelinating diseases [26][27][28]. The incidence of NMO is estimated to be approximately 4 per million of the population and the prevalence is somewhere between 3 and 44 per million, depending on ethnicity and geographic location [26][27][28][29].…”
Section: Neuromyelitis Opticamentioning
confidence: 99%
“…NMO is rare and accounts for only 1% of all demyelinating diseases [26][27][28]. The incidence of NMO is estimated to be approximately 4 per million of the population and the prevalence is somewhere between 3 and 44 per million, depending on ethnicity and geographic location [26][27][28][29]. Disease onset is usually in the fourth decade of life; women are affected more commonly than men (approximately 3:1); and non-Caucasians (especially Japanese) are affected more commonly than Caucasians [29][30][31][32].…”
Section: Neuromyelitis Opticamentioning
confidence: 99%